Ulcerative colitis: open trials in Latvia

• 2023-507853-13-00

  An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 2 · Eli Lilly & Co.

  Liepajas Regionala Slimnica SIA, Liepaja · Pauls Stradins Clinical University Hospital, Riga · Veselibas Centrs 4 SIA, Riga

  Registry updated 2026-11-05

• NCT07415044

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 2 · Eli Lilly and Company

  VCA poliklīnika Aura, Riga · Pauls Stradins Clinical Univeristy Hospital, Riga

  Registry updated 2026-11-04

• 2025-524404-29-00

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  Trial Treatment · Phase 2 · Eli Lilly & Co.

  Veselibas centru apvieniba AS, Riga · Pauls Stradins Clinical University Hospital, Riga

  Registry updated 2026-10-21

• NCT07845487

  A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 2 · Palisade Bio

  Site LV-003, Liepāja · Site LV-002, Riga · Site LV-001, Riga

  Registry updated 2026-10-21

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error